Pfizer (PFE) Announces FDA Approval of VELSIPITY for Adults with Moderately to Severely Active Ulcerative Colitis (UC) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
FDA Greenlights Pfizer s VELSIPITY for Severe Ulcerative Colitis miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Three teenagers are the brains and hands behind a new app that could make life easier for the millions of Americans living with inflammatory bowel diseases.
Etrasimod is the second oral sphingosine-1-phosphate (S1P) receptor approved in the US for treating moderate to severe active ulcerative colitis in adults.
Three teenagers are the brains and hands behind a new app that could make life easier for the millions of Americans living with inflammatory bowel diseases.